Anti-Cancer Drugs

An International Journal on Anti-Cancer Agents

Term*:

Price Type:

Country:

*Institutional subscriptions are Print only and do not include online access. For online access, please contact Ovid.

ISBN/ISSN:

0959-4973

Publication Frequency:

Published 10 times per year

Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and considers contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy.

An individual subscription includes 10 print issues and full-text online access to all current and back issues.
Visit the journal online at anti-cancerdrugs.com
ISBN/ISSN

0959-4973

Product Format

Print Journal + Online Access

Publication Frequency

Published 10 times per year
Paul Dent Ph.D
Professor Paul Dent, VCU Massey Cancer Center, Richmond VA, USA
--Research Articles - Original studies on basic preclinical or clinical research.
--Case Reports
--Review Articles
--Letters to the Editor
--Fast publication time
--Provides new developments and breakthrough research

Website: www.anti-cancerdrugs.com

$1,096.00

Item already added to cart.

Not Purchasable: Not done configuring

Added To Your Cart

ISBN/ISSN: 0959-4973

Quantity :